Olstein Capital Management L.P. Sells 11,000 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Olstein Capital Management L.P. trimmed its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 42.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,000 shares of the company’s stock after selling 11,000 shares during the quarter. Olstein Capital Management L.P.’s holdings in Prestige Consumer Healthcare were worth $1,290,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. Portside Wealth Group LLC raised its stake in Prestige Consumer Healthcare by 11.5% during the 1st quarter. Portside Wealth Group LLC now owns 8,000 shares of the company’s stock valued at $688,000 after buying an additional 828 shares during the last quarter. Congress Asset Management Co. boosted its stake in shares of Prestige Consumer Healthcare by 9.1% in the first quarter. Congress Asset Management Co. now owns 991,580 shares of the company’s stock worth $85,246,000 after acquiring an additional 82,838 shares during the period. GAMMA Investing LLC boosted its stake in Prestige Consumer Healthcare by 11,580.3% in the 1st quarter. GAMMA Investing LLC now owns 161,538 shares of the company’s stock worth $13,887,000 after purchasing an additional 160,155 shares during the period. Wealth Enhancement Advisory Services LLC lifted its stake in Prestige Consumer Healthcare by 14.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 8,315 shares of the company’s stock worth $649,000 after purchasing an additional 1,030 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth about $7,778,000. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Trading Up 0.6%

PBH stock opened at $85.11 on Monday. The stock has a market cap of $4.21 billion, a price-to-earnings ratio of 19.93, a PEG ratio of 2.69 and a beta of 0.45. The business’s 50-day moving average is $83.53 and its 200 day moving average is $82.50. Prestige Consumer Healthcare Inc. has a 12-month low of $63.79 and a 12-month high of $90.04. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, May 8th. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.30 by $0.02. The business had revenue of $296.52 million for the quarter, compared to analyst estimates of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The company’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.02 EPS. On average, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Analyst Ratings Changes

PBH has been the topic of several recent research reports. Oppenheimer increased their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Wall Street Zen upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 17th. Finally, Royal Bank of Canada upgraded Prestige Consumer Healthcare to a “hold” rating in a research note on Thursday, May 8th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $93.33.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.